Cardiac sympathetic denervation preceding motor signs in Parkinson disease

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • David S. Goldstein - , National Institutes of Health (NIH) (Autor:in)
  • Yehonatan Sharabi - , National Institutes of Health (NIH) (Autor:in)
  • Barbara I. Karp - , National Institutes of Health (NIH) (Autor:in)
  • Oladi Bentho - , National Institutes of Health (NIH) (Autor:in)
  • Ahmed Saleem - , National Institutes of Health (NIH) (Autor:in)
  • Karel Pacak - , Eunice Kennedy Shriver National Institute of Child Health and Human Development (Autor:in)
  • Graeme Eisenhofer - , National Institutes of Health (NIH) (Autor:in)

Abstract

There is substantial interest in identifying biomarkers to detect early Parkinson disease (PD). Cardiac noradrenergic denervation and attenuated baroreflex-cardiovagal function occur in de novo PD, but whether these abnormalities can precede PD has been unknown. Here we report the case of a patient who had profoundly decreased left ventricular myocardial 6-[18F]fluorodopamine-derived radioactivity and low baroreflex-cardiovagal gain, 4 years before the onset of symptoms and signs of PD. The results lead us to hypothesize that cardiac noradrenergic denervation and decreased baroreflex-cardiovagal function may occur early in the pathogenesis of PD.

Details

OriginalspracheEnglisch
Seiten (von - bis)S47-S50
FachzeitschriftCleveland Clinic journal of medicine
Jahrgang76
AusgabenummerSuppl 2
PublikationsstatusVeröffentlicht - 2009
Peer-Review-StatusJa
Extern publiziertJa

Schlagworte

ASJC Scopus Sachgebiete